![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-to-host-in-person-investor-day-to-discuss-current-treatment-landscapes-and-clinical-results-for-fabry-disease-and-uncontrolled-gout-302171884.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-to-present-at-the-2024-bio-international-convention-302158047.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-reports-first-quarter-2024-financial-and-business-results-302142244.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-to-announce-first-quarter-2024-financial-and-business-results-on-may-10-2024-302134924.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-to-announce-fiscal-year-2023-financial-and-business-results-on-march-14-2024-302082682.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-to-participate-in-the-2024-bio-ceo--investor-conference-302069408.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-issues-2024-letter-to-stockholders-302022312.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-reports-third-quarter-2023-financial-and-business-results-301978381.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-to-announce-third-quarter-2023-financial-and-business-results-on-november-6-2023-301971169.html
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-issues-statement-regarding-security-situation-in-israel-301950666.html